Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination

Since 2009, a cancer vaccine clinical trial was conducted with melanoma antigen gene-A4 as an immunogenic agent. The levels of IgG1, IgG2 and IgG3, which are known to be Type 1 T helper cell-associated antibodies, and the levels of IgG4 and IgE, which are known to be Type 2 T helper cell-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Abiko, Takehiro, Tsuchikawa, Takahiro, Miyauchi, Kengo, Wada, Masataka, Kyogoku, Noriaki, Shichinohe, Toshiaki, Miyahara, Yoshihiro, Kageyama, Shinichi, Ikeda, Hiroaki, Shiku, Hiroshi, Hirano, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795923/
https://www.ncbi.nlm.nih.gov/pubmed/29467889
http://dx.doi.org/10.3892/ol.2018.7767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795923/
https://www.ncbi.nlm.nih.gov/pubmed/29467889
http://dx.doi.org/10.3892/ol.2018.7767

Ejemplares similares